4//SEC Filing
Lehr Martin A. 4
Accession 0001842952-23-000027
CIK 0001842952other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:04 PM ET
Size
5.5 KB
Accession
0001842952-23-000027
Insider Transaction Report
Form 4
Lehr Martin A.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-13+287,544→ 287,544 totalExercise: $0.84Exp: 2033-02-12→ Common Stock (287,544 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2024, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.
Documents
Issuer
Context Therapeutics Inc.
CIK 0001842952
Entity typeother
Related Parties
1- filerCIK 0001861989
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:04 PM ET
- Size
- 5.5 KB